drugset / Trial / NCT00892502
Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether treatment with Bismuth can reduce the toxicity of chemotherapy and radiotherapy in patients with malignant diseases of the blood.
Timeline
- Start
- 2009-05
- Primary completion
- 2012-01
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bismuth Potassium Citrate | Unknown | 500 mg | — |